Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166509 | SCV000217309 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000204108 | SCV000261138 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001721083 | SCV000515430 | likely benign | not provided | 2020-10-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166509 | SCV000682361 | likely benign | Hereditary cancer-predisposing syndrome | 2016-05-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000423866 | SCV000694329 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001721083 | SCV003800195 | likely benign | not provided | 2022-03-23 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589799 | SCV005082372 | benign | Familial cancer of breast | 2024-06-10 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004552923 | SCV004709784 | likely benign | ATM-related disorder | 2021-02-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |